Showing results (2031-2040 of 3,477) with videos related to

Sort By:
Pageof 348
Clinical Pharmacokinetics|June 18, 2016
Bevacizumab Pharmacokinetics Influence Overall and Progression-Free Survival in Metastatic Colorectal Cancer PatientsMorgane Caulet, Thierry Lecomte, Olivier Bouché, et al.
Clinical Pharmacokinetics|October 1, 1987
The influence of food on the bioavailability of a slow release theophylline preparationJ J Thebault, J M Aiache, F Mazoyer, et al.
Clinical Pharmacokinetics|February 5, 2002
Drug interactions with patient-controlled analgesiaJorn Lotsch, Carsten Skarke, Irmgard Tegeder, et al.
Clinical Pharmacokinetics|April 5, 2001
The development of the bradykinin agonist labradimil as a means to increase the permeability of the blood-brain barrier: from concept to clinical evaluationD F Emerich, R L Dean, C Osborn, et al.
Clinical Pharmacokinetics|December 7, 2000
Pharmacokinetics and pharmacodynamics of cephalosporins in cerebrospinal fluidI Lutsar, I R Friedland
Clinical Pharmacokinetics|December 7, 2000
Articular diffusion of meloxicam after a single oral dose: relationship to cyclo-oxygenase inhibition in synovial cellsF Lapicque, P Vergne, J Y Jouzeau, et al.
Clinical Pharmacokinetics|September 12, 2002
Clinical significance of the cytochrome P450 2C19 genetic polymorphismZeruesenay Desta, Xiaojiong Zhao, Jae-Gook Shin, et al.
Clinical Pharmacokinetics|September 12, 2002
Pharmacokinetics of omeprazole given by continuous intravenous infusion to patients with varying degrees of hepatic dysfunctionJosep M Piqué, Faust Feu, Gloria de Prada, et al.
Clinical Pharmacokinetics|August 10, 2002
Lack of clinically relevant interaction between desloratadine and erythromycinChristopher Banfield, Thomas Hunt, Larisa Reyderman, et al.
Clinical Pharmacokinetics|August 10, 2002
Desloratadine has no clinically relevant electrocardiographic or pharmacodynamic interactions with ketoconazoleChristopher Banfield, Jerry Herron, Anther Keung, et al.
Pageof 348